The engineered virgin-equivalent pcr resin market is projected to grow from USD 2,980.0 million in 2026 to USD 6,199.2 million by 2036, at a CAGR of 7.6%. Polyethylene (PE) will dominate with a 42.0% market share, while virgin-equivalent performance will lead the performance level segment with a 55.0% share.